Levofloxacin Injection, Solution
Product Images NDC 68083-415

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 68083-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levofloxacin-spl-bag-100-ml (Levofloxacin Spl Bag 100 mL)

Levofloxacin in 5% Dextrose Injection 500 mg per 100 mL (5 mg/mL) intravenous solution. The label states infusion instructions, pharmacist attention notes, and storage precautions. The product is manufactured by Gland Pharma Limited, India. The container size shown is 100 mL, and the label includes NDC 68083-415-01 and barcode.*

FDA Label Image

Levofloxacin-spl-bag-150-ml (Levofloxacin Spl Bag 150 mL)

Label for Levofloxacin in 5% Dextrose Injection 750 mg per 150 mL (5 mg/mL), intravenous infusion solution. The label specifies use for intravenous infusion over 90 minutes and includes storage and handling instructions. Manufactured by Gland Pharma Limited, India. The container size is 150 mL and it is for prescription use only.*

FDA Label Image

Levofloxacin-spl-bag-50-ml (Levofloxacin Spl Bag 50 mL)

Label for Levofloxacin in 5% Dextrose Injection 250 mg per 50 mL (5 mg/mL) intravenous solution. The label includes usage instructions to infuse over 60 minutes, and cautions such as dispensing the medication guide and discarding any unused portion. Manufactured by Gland Pharma Limited, the container volume is 50 mL, and the product is for single-dose use only.*

FDA Label Image

Levofloxacin-spl-figure-1 (Levofloxacin Spl Figure 1)

A line graph comparing plasma concentration (µg/mL) over time (hours) after administration of 750 mg levofloxacin as either an oral tablet or intravenous infusion. The graph shows plasma levels rising quickly with both forms, peaking near the start, and gradually declining over 36 hours, with intravenous infusion data represented by triangles and oral tablet data by circles.*

FDA Label Image

Levofloxacin-spl-figure-2 (Levofloxacin Spl Figure 2)

A line graph comparing plasma concentration (µg/mL) over time (hours) for levofloxacin 500 mg administered as an intravenous injection (i.v.) and as an oral tablet (p.o.). The graph shows concentration peaking around initial hours for both routes, with levels decreasing over 36 hours.*

FDA Label Image

Levofloxacin-spl-pouch-100-ml (Levofloxacin Spl Pouch 100 mL)

Label front and back of levofloxacin in 5% dextrose injection, 500 mg per 100 mL (5 mg/mL) intravenous infusion solution. The front label includes usage instructions, storage conditions, manufacturer (Gland Pharma Limited, Hyderabad, India), and volume (100 mL). The back label repeats the product name, strength, volume, and infusion route.*

FDA Label Image

Levofloxacin-spl-pouch-150-ml (Levofloxacin Spl Pouch 150 mL)

Levofloxacin in 5% Dextrose Injection 750 mg per 150 mL intravenous solution pouch front and back. The front displays usage instructions, storage details, and manufacturer Gland Pharma Limited, Hyderabad, India, along with a barcode and NDC number 68083-416-01. The back label repeats the drug name, strength, and volume.*

FDA Label Image

Levofloxacin-spl-pouch-50-ml (Levofloxacin Spl Pouch 50 mL)

Levofloxacin in 5% Dextrose Injection 250 mg per 50 mL (5 mg/mL) intravenous infusion solution in a 50 mL bag pouch. The front label includes dosing and storage instructions, manufacturer details (Gland Pharma Limited, Hyderabad, India), and the NDC 68083-414-01. The back label repeats the product name, strength, volume, and infusion route.*

FDA Label Image

Levofloxacin-spl-structure (Levofloxacin Spl Structure)

Chemical structure of levofloxacin as depicted in the image, showing its molecular components including a fluorine atom, carboxylic acid group, and the characteristic quinolone core with specific stereochemistry and a half molecule of water (H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.